SBC Medical Group CEO and Doctors Present at the 114th JSAS Conference

SBC Medical Group Holdings Inc. (Irvine, CA; CEO: Yoshiyuki Aikawa) participated in the 114th Japan Society of Aesthetic Surgery (JSAS) held at The Okura Tokyo on May 28-29, 2026, under the theme 'Tradition Meets Innovation from Japan'. CEO Aikawa chaired a symposium focused on integrating medicine, marketing, customer management, and AI technology to lead discussion on future aesthetic medicine from a management perspective. Five doctors from the SBC clinic network also presented research across various sessions. Dr. Keiichiro Kasai discussed hair regeneration and anti-aging treatments. Dr. Soichiro Morikawa presented on skin rejuvenation combination therapies and polynucleotide clinical applications. Dr. Daisuke Sato showcased SMAS sub-dissection in facelifts. Dr. Shunsuke Nagakura evaluated the utility of artificial dermis in nasolabial fold treatments based on 50 cases. Dr. Atsushi Hayashi presented on adverse events related to botulinum toxin injections in the cheek. SBC remains committed to promoting advanced initiatives and improving safety, transparency, and sustainable value in aesthetic medicine.